Found 270 matching trials
Delayed Tolerance Through Mixed Chimerism PHASE1 This study will examine the safety and effectiveness of a bone marrow trans...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial
TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors PHASE2 The purpose of this study is to find out if removing a specific type of whi...
Show More Location
Memorial SloanKettering Cancer Center
Learn More & Join Trial
Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation PHASE1 This is a phase I single center dose escalation study with an extension at ...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia PHASE3 This randomized phase III trial studies how well imatinib mesylate works in...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia PHASE4 The goal of this clinical trial is to compare a short course of antibiotics...
Show More Location
University Hospitals Leuven
Learn More & Join Trial
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor PHASE2 This is a Phase II, open-label, two strata, multicenter, prospective study ...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
Busulfan and Cyclophosphamide Followed By ALLO BMT NA This is a treatment guideline to allow routine clinical data to be collecte...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma PHASE1 Neuroblastoma is a malignant tumor of the sympathetic nervous system. It is...
Show More Location
Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian
Learn More & Join Trial
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma PHASE2 RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Show More Location
City of Hope Medical Center
Learn More & Join Trial